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Summary
There are very few reports on pancreatic volumetry using multidetector-row computed 
tomography (MDCT). In the present study, we performed pancreatic volumetry for 148 patients 
who had undergone pancreatectomy at this institution between June 2006 and May 2011 and for 
50 patients who had undergone laparoscopic cholecystectomy (LC) for cholecystolithiasis with 
no choledocholithiasis between January 2008 and May 2011. We then conducted a comparative 
investigation of pancreatic volume between the two groups.
A strong positive correlation was observed between pancreatic volume and body surface area (BSA) 
in the LC patients. On the basis of these results, we investigated pancreatic volume by disease using 
a corrected pancreatic volume that excluded BSA. The corrected pancreatic volume for patients 
with ordinary pancreatic cancer (invasive ductal carcinoma; IDC) was significantly smaller than 
that for patients with intraductal papillary mucinous neoplasm (IPMN) or bile duct cancer (BDC) 
and LC patients (P < 0.001). Furthermore, the corrected pancreatic volume for BDC patients was 
significantly larger than the volume for IPMN or LC patients. Corrected pancreatic volume is 
therefore useful for the differential diagnosis of tumours of the pancreatic head.
Key term: Pancreatic volumetry
Background and Objectives
Recent advances in workstations for diagnostic 
radiography have enabled easy and accurate 
construction of three-dimensional (3D) images 
of the blood vessels and solid organs. 3D images 
obtained through this process are now widely used 
for the preoperative simulation of surgery and 
liver volumetry. In particular, to cure cancers of 
the liver, gall bladder and pancreas, it is necessary 
to achieve R0 resection through surgery(1), and, 
to that end, the use of 3D images to ascertain 
clinically accurate surgical anatomy before surgery 
is extremely valuable(2).
There are very few existing reports of pancreatic 
volumetry conducted using multidetector-
row thin-slice computed tomography (MDCT), 
indicating that only limited findings have been 
obtained for pancreatic volume(3-6). In the present 
study, we performed pancreatic volumetry for 
148 patients who had undergone pancreatectomy 
and 50 patients who had undergone laparoscopic 
cholecystectomy (LC) for cholecystolithiasis 
with no choledocholithiasis at our institution 
and investigated the parameters that influence 
pancreatic volume.
Concomitant pancreatitis with accompanying 
fibrosis and atrophy in patients with pancreatic 
tumours, particularly invasive ductal carcinoma 
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(IDC), is being increasingly recognised(8-12). The 
degree of pancreatic atrophy can offer a clue to 
the pathological characteristics of the tumour. 
However, till date, the nature of the changes in 
pancreatic volume related to pancreatic tumour 
or disease was not known. Here we used MDCT to 
conduct a comparative investigation of pancreatic 
volume by disease.
Subjects and Methods
Fifty-three patients who had undergone LC at 
this institution between January 2008 and May 
2011 were selected for the study. Patients who did 
not undergo contrast-enhanced CT because of the 
detection of choledocholithiasis, pancreatic lesions, 
cancer or renal dysfunction at the time of surgery 
were excluded, leaving 50 patients suitable for the 
investigation. Pancreatic volume was calculated 
using contrast-enhanced CT with a 1-mm slice 
thickness that was conducted immediately before 
surgery. A workstation (Zio station; ZIO SOFT 
Co., Tokyo) was used for image processing. The 
cross-sectional areas, calculated using free-hand 
tracing, were added to obtain the volume of the 
entire pancreas (Figure 1). The correlation of the 
resulting pancreatic volume with body surface area 
(BSA), height, weight, body mass index (BMI) and 
age was investigated using the Pearson correlation 
coefficient. The Mann-Whitney U test was used 
to assess gender differences, and P < 0.05 was 
considered statistically significant.
Of the 153 patients who underwent pancreatectomy 
at this department between June 2006 and May 
2011, 148 with evaluable preoperative contrast-
enhanced CT scans were included in the study. The 
diagnoses for the patients were as follows: IDC (n 
= 38), intraductal papillary mucinous neoplasm 
(IPMN; n = 61), bile duct cancer (BDC; n = 19), 
carcinoma of the papilla of Vater (Vater Ca; n = 7) 
and others (n = 24; Table 3). The 50 patients who 
had undergone LC were used as a control group. 
Pancreatic volume was calculated in the same 
manner as described above. Furthermore, the 
volume of tumours and cysts and expanded 
pancreatic duct volume were subtracted to 
accurately calculate the actual pancreatic volume 
(Figure 1). A comparison of pancreatic volume 
was conducted on the basis of the investigation 
of the 50 LC patients using a corrected pancreatic 
Figure 1 Method of calculating pancreatic volume
 
Actual pancreatic volume + pancreatic duct volume 
+ cyst volume
 
Pancreatic duct volume + cyst volume
 
Actual pancreatic volume
Table 1 Background of the LC patients
Total number 50 (M:F 25:25)
Gender M　85.3ml：　F　66.3ml
Age 60.8 yrs ± 14.3
Weight 61.8 kg ± 11.8
Height 160.2 cm ± 9.2
BMI 23.9 ± 3.3
BSA 1.6 m2 ± 0.19
Table 2 Correlation between each parameter and 
pancreatic volume in LC patients
Gender p<0.001 
Age r=-0.22 p=0.11 
Weight r-=0.536 p<0.001 
Height r=0.583 p<0.001
BMI r=0.26 p=0.06
BSA r-=0.586 p<0.001
pancreatic volumetry
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volume that excluded BSA, enabling a comparative 
investigation of the corrected pancreatic volume by 
disease. Testing was conducted using the Mann-
Whitney U test, and P < 0.05 was considered 
statistically significant.
Results
The average pancreatic volume for the 50 LC 
patients was 75.7 ± 21.8 mL. Preoperative 
complications included diabetes in 1 patient, 
oral treatment for hypertension in 16 and oral 
treatment for hyperlipidaemia in 5. The mean 
values and standard deviations for age, height, 
weight, BSA and BMI were 60.8 ± 14.3 years, 160.2 
± 9.2 cm, 61.8 ± 11.8 kg, 1.60 ± 0.19 m2 and 23.9 ± 
3.27 kg/m2, respectively (Table 1). The correlation 
with pancreatic volume was confirmed for each 
parameter (Table 2) as follows: age, r = － 0.22, 
P = 0.11; height, r = 0.583, P < 0.001; weight, r 
= 0.536, P < 0.001; BSA, r = 0.586, P < 0.001 and 
BMI, r = 0.26, P = 0.06. The strongest correlation 
was observed for BSA, which showed a strong 
positive correlation (Figure 2). With regard to age 
and BMI, the correlation was confirmed by the 
corrected pancreatic volume obtained by dividing 
the pancreatic volume with BSA. The relationships 
of age and BMI with corrected pancreatic volume 
were not significant as follows: r = － 0.09, P = 0.53 
and r = 0.06, P = 0.67, respectively. Between the 
genders, the correlation was stronger for males 
(P < 0.001). However, when corrected pancreatic 
volume was used, no significant gender difference 
was observed (P = 0.07).
Pancreatic volume by disease was calculated using 
a corrected pancreatic volume that excluded BSA. 
The average corrected pancreatic volumes for the 
patients who underwent pancreatectomy and the 
LC patients were 43.2 ± 13.3 mL/m2 and 46.1 ± 
10.8 mL/m2, respectively. The corrected pancreatic 
volume was compared by disease for the patients 
who underwent pancreatectomy. The average 
corrected pancreatic volume for the 38 IDC patients 
was 35.6 ± 12.2 mL/m2. Of these, the average 
corrected pancreatic volume for the 20 patients 
who underwent pancreaticoduodenectomy was 34.0 
± 13.5 mL/m2, while that for the 18 patients who 
underwent distal pancreatectomy was 37.5 ± 10.5 
Figure 2 Correlation between pancreatic volume 
and BSA
Table 3 Background of patients who underwent pancreatectomy
Total number 148
M:F 96:52 
Average age 66.8 years
Disease Invasive ductal carcinoma (IDC), n = 38
Intraductal papillary mucinous neoplasm (IPMN), n = 61
Intraductal papillary mucinous adenoma (IPMA), n = 43
Intraductal papillary mucinous adenocarcinoma (IPMC), n = 18
Bile duct cancer (BDC), n = 18
Carcinoma of the papilla of Vater (Vater Ca), n = 7
Neuroendocrine tumour, n = 5
Mucinous cystic tumour (MCN), n = 4
Serous cystic neoplasm (SCN), n = 3
Acinar cell carcinoma, n = 2
Pancreatic pseudocyst, n = 2
Splenic artery aneurysm, n = 1 
Solid pseudopapillary tumour
(SPT), n = 1
Retention cyst, n = 1
Myxosarcoma, n = 1
Gall-bladder cancer, n = 1
Stomach cancer, n = 1
Chronic pancreatitis, n = 1
Arteriovenous malformation, n = 1
Type of surgery Pancreaticoduodenectomy (PD), n = 84
Distal pancreatectomy with splenectomy (DPS), n = 50
Spleen-preserving distal pancreatectomy (SpDP), n = 14
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mL/m2. The difference between the patients who 
underwent pancreaticoduodenectomy and those 
who underwent distal pancreatectomy was not 
significant (P = 0.32).
The average corrected pancreatic volume for the 
IPMN patients was 45.0 ± 13.3 mL/m2. Of these, 
the average corrected pancreatic volume for the 33 
patients who underwent pancreaticoduodenectomy 
was 48.5 ± 15.7 mL/m2, while that for the 28 
patients who underwent distal pancreatectomy was 
42.3 ± 8.8 mL/m2, with no significant difference (P 
= － 0.10).
The average corrected pancreatic volumes for the 
BDC and Vater Ca patients were 52.3 ± 9.3 mL/m2 
and 50.8 ± 1 8 mL/m2, respectively (Table 4).
The corrected pancreatic volume for the IDC 
patients was significantly smaller than that for 
the IPMN, BDC and LC patients (P < 0.001). The 
corrected pancreatic volume for the BDC patients 
was significantly larger than that for the LC and 
IPMN patients (P < 0.05; Figure 3). 
Discussion
Till date, there have been very few detailed 
investigations of pancreatic volume. Djuric-
Stefanovic et al. used the same MDCT method as 
used in the present study to conduct volumetry of 
the normal pancreas and reported that pancreatic 
volume was correlated with gender, craniocaudal 
diameter of the pancreas and transverse diameter 
of the first lumbar vertebra; however, it was not 
correlated with age(4). Shirakawa et al. investigated 
the rate of pancreatectomy using MDCT and 
reported that it was possible to predict the onset of 
diabetes following distal pancreatectomy(5). Goda 
et al. and Sakata et al. also reported a correlation 
between pancreatic volume and endocrine function 
using pancreatic volumetry(6,7). Goda et al. claimed 
that pancreatic volume is strongly correlated with 
BSA and used a corrected value excluding BSA 
to compare pancreatic volume using the same 
method used in the present study. With regard 
to volumetry of other organs, Urata et al. have 
reported a standard liver volume(13), and Kaneko 
et al. have investigated the volume of the spleen(14). 
In the present study, we used a 1-mm slice MDCT 
image to conduct precise pancreatic volumetry. We 
investigated the normal pancreas and identified 
the parameters influencing pancreatic volume. To 
Figure 3 Corrected pancreatic volume by disease
Table 4 Corrected pancreatic volume by disease in patients who underwent pancreatectomy
Number of patients
Average value
ml/m2
Median value
ml/m2
Standard deviation
LC 50 46.1 44.3 ±10.8
All pancreatic diseases 148 43.2 42.6 ±13.3
IDC Total 38 35.6 34.2 ±12.2
PD 20 34.0 33.3 ±13.5
DP 18 37.5 35.6 ±10.5
IPMN Total 61 45.0 43.1 ±13.3
PD 33 48.5 44.3 ±15.7
DP 28 42.3 42.5 ±8.8
BDC 18 52.3 53.1 ±9.3
Vater Ca 7 50.8 44.5 ±18
Other pancreatic disease 24 41.2 39.9 ±10.8
pancreatic volumetry
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our knowledge, this is the first report on changes 
in pancreatic volume in patients with pancreatic 
disease.
First ,  we conducted volumetry under  the 
supposition that the pancreas of a patient 
with choledocystolithiasis in the absence of 
cholecystolithiasis was representative of a normal 
pancreas. We then investigated the correlation 
between pancreatic volume and BSA, height, 
weight, BMI and age. Pancreatic volume showed a 
positive correlation with BSA, height and weight, 
with the strongest correlation between pancreatic 
volume and BSA. In short, we considered that 
pancreatic volume increases with body size. 
However, no significant correlation was observed 
with BMI or age, and there was no obesity-induced 
swelling or ageing-induced atrophy. Therefore, 
to eliminate the effects of differences in body size 
when comparing pancreatic volume, we deemed it 
appropriate to correct the volume for BSA. The 
comparisons in this study were therefore conducted 
using a corrected pancreatic volume that excluded 
BSA. 
Caudal pancreatic atrophy is a phenomenon that 
is frequently observed in patients with pancreatic 
cancer(7-11); therefore, the presence of pancreatic 
atrophy suggests the possible presence of pancreatic 
cancer. However, till date, there are no studies that 
compare pancreatic volume in patients with the 
volume of a normal pancreas; therefore, the degree 
of atrophy is difficult to determine. In the present 
study, the corrected pancreatic volume for IDC 
patients was significantly smaller than that for 
BDC, IPMN and LC patients, indicating pancreatic 
atrophy. We therefore succeeded in confirming the 
presence of pancreatic atrophy in IDC patients. 
The mechanism underlying pancreatic atrophy 
in IDC is thought to be obstructive pancreatitis 
caused by blockage of the main pancreatic duct(8-
12). However, there are few reports on the degree of 
atrophy related to obstructive pancreatitis that is 
determined by CT. Because the extent of atrophy 
in IDC of the pancreatic head is potentially greater 
than that in patients with IDC of the pancreatic 
tail, we anticipated a smaller volume in patients 
with IDC of the pancreatic head. However, no 
significant difference was observed in the corrected 
pancreatic volume between IDC patients who 
had undergone pancreaticoduodenectomy and 
those who had undergone distal pancreatectomy. 
Pancreatic atrophy in IDC may therefore extend to 
the entire pancreas.
Furthermore, the corrected pancreatic volume 
for BDC patients was significantly larger than 
that for LC or IPMN patients. This was thought 
to be a result of pancreatic swelling. There are 
no reports of pancreatic volume in patients with 
inferior bile duct cancer, and the mechanism 
underlying pancreatic swelling remains unclear. 
Bile congestion secondary to biliary obstruction 
and the accompanying metabolic abnormalities 
may have an influence.
In patients with tumours of the pancreatic head, it 
is often difficult to differentiate between invasive 
ductal carcinoma and pancreatic tumours. In these 
patients, the degree of pancreatic atrophy can help 
with the diagnosis. In particular, we believe that 
this method can be useful to differentiate tumours 
of the pancreas from inferior bile duct cancer. 
Conclusions
Pancreatic volume is correlated with body size, 
but not with age or obesity. Corrected pancreatic 
volume is useful for the differential diagnosis of 
tumours of the pancreatic head.
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